Case Report on the Five-year Survival of a Patient with Rectal Cancer Treated with Integrative Medicine After Resection and Chemoradiation Therapy

B. Jeong, Jisoo Kim, Y. Jung, Kyung-dug Park, Yoona Oh, Sunhwi Bang
{"title":"Case Report on the Five-year Survival of a Patient with Rectal Cancer Treated with Integrative Medicine After Resection and Chemoradiation Therapy","authors":"B. Jeong, Jisoo Kim, Y. Jung, Kyung-dug Park, Yoona Oh, Sunhwi Bang","doi":"10.22246/jikm.2023.44.3.578","DOIUrl":null,"url":null,"abstract":"Objectives: This is a five-year survival and complete response (CR) report on rectal cancer treated with western medicine and Korean traditional medicine.Method: A 25-year-old woman diagnosed with rectal cancer visited ○○ Korean traditional medicine hospital after neoadjuvant concurrent chemoradiation therapy, chemotherapy, and low anterior resection with regional lymph node dissection. She was treated with Korean traditional medicine, including acupuncture, abdominal moxibustion, wild ginseng pharmacopuncture, and herbal medicine, which was based on integrated medicine therapy (IMT), from January 2018 to February 2022. The tumor size was measured by scanning with computed tomography (CT), magnetic resonance imaging, and positron-emission tomography/CT. Adverse events were evaluated using laboratory conclusion and National Cancer Institute Common Terminology Criteria for Adverse Events version 5.0.Result: During four years of treatment, IMT maintained safety. The patient finally reached five-year survival without any recurrence or complication (CR) on March 11, 2022.Conclusion: We suggest that an integrative approach including Korean traditional medicine can be a meaningful treatment option for rectal cancer. Further studies should be performed to establish the proper treatment protocol of integrative medicine for rectal cancer.","PeriodicalId":22826,"journal":{"name":"The Journal of Internal Korean Medicine","volume":"5 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"The Journal of Internal Korean Medicine","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22246/jikm.2023.44.3.578","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Objectives: This is a five-year survival and complete response (CR) report on rectal cancer treated with western medicine and Korean traditional medicine.Method: A 25-year-old woman diagnosed with rectal cancer visited ○○ Korean traditional medicine hospital after neoadjuvant concurrent chemoradiation therapy, chemotherapy, and low anterior resection with regional lymph node dissection. She was treated with Korean traditional medicine, including acupuncture, abdominal moxibustion, wild ginseng pharmacopuncture, and herbal medicine, which was based on integrated medicine therapy (IMT), from January 2018 to February 2022. The tumor size was measured by scanning with computed tomography (CT), magnetic resonance imaging, and positron-emission tomography/CT. Adverse events were evaluated using laboratory conclusion and National Cancer Institute Common Terminology Criteria for Adverse Events version 5.0.Result: During four years of treatment, IMT maintained safety. The patient finally reached five-year survival without any recurrence or complication (CR) on March 11, 2022.Conclusion: We suggest that an integrative approach including Korean traditional medicine can be a meaningful treatment option for rectal cancer. Further studies should be performed to establish the proper treatment protocol of integrative medicine for rectal cancer.
1例直肠癌经中西医结合手术切除加放化疗后5年生存率分析
目的:这是一份西药和韩药治疗直肠癌的5年生存和完全缓解(CR)报告。方法:一名25岁的直肠癌患者在接受新辅助同步放化疗、化疗、低位前切除术并区域淋巴结清扫后到〇〇韩国中医院就诊。从2018年1月到2022年2月,她接受了针灸、腹灸、野生人参药物穿刺、以综合医学疗法(IMT)为基础的草药等韩国传统医学的治疗。通过计算机断层扫描(CT)、磁共振成像和正电子发射断层扫描/CT测量肿瘤大小。不良事件采用实验室结论和美国国家癌症研究所不良事件通用术语标准5.0版进行评估。结果:在4年的治疗中,IMT保持了安全性。患者最终于2022年3月11日达到5年生存期,无复发或并发症(CR)。结论:我们认为结合韩国传统医学治疗直肠癌是一种有意义的治疗选择。需要进一步的研究来建立合适的直肠癌中西医结合治疗方案。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信